Pinsent Masons appoints new London partner in expanding Life Sciences team

02 Sep 2019 | 09:45 am | 2 min. read

International law firm Pinsent Masons has further enhanced its international life sciences and technology sector capabilities with the appointment of Nicole Jadeja in its London office.

Nicole will be joining from Fieldfisher, where she was the co-head of Life Sciences.

Nicole is a market leading life sciences lawyer and patent litigation specialist. She is recognised in the market as representing a wide-range of companies across the life sciences sector, including high-profile companies in commercially sensitive multi-jurisdiction patent disputes and innovative biotech companies developing cutting edge technologies. With a scientific background and experience in clinical trials, Nicole is well placed to understand and advise clients on issues relevant to the sector.

As a partner within Pinsent Masons' Life Sciences team, Nicole will work alongside the strong team of patent litigation specialists, led by Clare Tunstall, on cutting edge pharmaceutical cases.

Clare Tunstall, Head of Life Sciences at Pinsent Masons said: "Nicole's appointment is testament to our continued investment in appointing talented individuals who enhance our capabilities in servicing our international client base. Nicole's depth of experience and knowledge of the Life Sciences sector will both complement and enhance our offering. We have a growing international team who advise across a range of IP, transaction and regulatory matters and we look forward to welcoming Nicole to this."

Nicole is Vice Chair of the IP committee of the BioIndustry's Association and a member of the Chartered Institute of Patent Attorney's life sciences committee. Recently, Nicole advised both organisations on their successful intervention in high-profile life sciences cases before the UK Supreme Court.

Florian Van Baum, Head of the Advanced Manufacturing and Technology sector adds: "Nicole's reputation as a market leading practitioner who brings deep sector knowledge and expertise will add invaluable strength to our team. Her diverse experience supplements Pinsent Masons' international Advanced Manufacturing and Technology sector and is a fantastic addition to our Life Sciences team."

Nicole's appointment continues the expansion of Pinsent Masons' international Life Sciences team and follows the firm's recent recruitment of Michael Finn in the firm's Dublin office. In addition, Legal Director and Intellectual Property specialist, Jules Fabre, has now relocated to the firm's office in Paris. Here he will work with clients in the Life Sciences and Pharmaceutical sector on complex French and cross border patent and SPC litigations.

Key Contacts

Clare Tunstall

Clare Tunstall

Partner, Head of IP & Life sciences

View Profile
Dr. Florian von Baum

Dr. Florian von Baum

Rechtsanwalt, Partner, Sector Head Technology, Science & Industry

View Profile

Latest press releases

Show me all press releases

Pinsent Masons launches in Luxembourg

Multinational law firm Pinsent Masons has expanded into Luxembourg, launching a full-service law firm, having recruited a significant number of former Wildgen partners and their teams.

Pinsent Masons appoints Pamela McDonald as new head of its Doha office

Multinational law firm Pinsent Masons has named international arbitration partner Pamela McDonald as the new head of its Doha office.

Multiple wins for Pinsent Masons at China Business Law Awards 2022

Multinational law firm Pinsent Masons has won in seven categories at China Business Law Journal's annual awards.

People who viewed this press release also viewed

Show me all press releases

Multiple wins for Pinsent Masons at China Business Law Awards 2022

Multinational law firm Pinsent Masons has won in seven categories at China Business Law Journal's annual awards.

Pinsent Masons Advises Accord Healthcare in Exclusive Licence Agreement with Myovant Sciences to Commercialise ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe

Pinsent Masons represented Accord Healthcare Ltd in an exclusive license agreement with Myovant Sciences to commercialise relugolix, Myovant’s advanced hormone-sensitive prostate cancer treatment, under the trade name ORGOVYX® in the European Economic Area, United Kingdom, Switzerland and Turkey.

Pinsent Masons advises on landmark financing of FINN

Multinational law firm Pinsent Masons has advised French investment company Korelya Capital on the EUR 100+ million financing of car subscription start-up FINN.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts